Inactivate RAAS through non-angiotensin converting enzyme pathway, which significantly reduce the level of Ang II, reduce the infarct size, protect cardiac function, reduce myocardial fibrosis, and inhibit TGF-β1 pathway. The gene discussed is TGFB1; the disease is Myocardial fibrosis.